ClassID:

21254

A61K45/00 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  - 

Recent Application in this class:
#301
20180271895
2018-09-27

Method for suppressing tumors by miR-200 family inhibition

#302
20180264015
2018-09-20

Leukocyte infiltration promoting agent and antitumor immunostimulatory agent

#303
20180256668
2018-09-13

Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patient

#304
20180246081
2018-08-30

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#305
20180244771
2018-08-30

Immunity enhancing agent for cancer by Allergin-1 antagonist

#306
20180243472
2018-08-30

Implant for tissue repair including chitosan

#307
20180243355
2018-08-30

Anti-cancer agent comprising HVJ-E and CXCL2

#308
20180243338
2018-08-30

Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine

#309
20180243284
2018-08-30

Therapeutic agent or treatment method for Philadelphia chromosome-positive (Ph+) acute lymphocytic leukemia (ALL) having IKZF1 mutation

#310
20180243226
2018-08-30

Polymeric bile acid nanocompositions targeting the pancreas and colon

#311
20180238875
2018-08-23

Circulating astrocytes and MFSD2A as biomarkers

#312
20180236050
2018-08-23

Method of treating depression

#313
20180236005
2018-08-23

FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE

#314
20180221321
2018-08-09

Methods and products related to glutaminase inhibitors

#315
20180214553
2018-08-02

GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION

#316
20180214410
2018-08-02

Development of dietary therapy in cancer

#317
20180209992
2018-07-26

Methods and compositions for treatment of autoimmune hepatitis

#318
20180206461
2018-07-26

INHIBITING CTRP5 ACTION TO IMPROVE INSULIN RESISTANCE ASSOCIATED WITH OBESITY AND TYPE 2 DIABETES

#319
20180201608
2018-07-19

Compositions and methods for treating neurodegenerative diseases

#320
20180200356
2018-07-19

Immune inducer

#321
20180194773
2018-07-12

Bicyclic heterocyclic amide derivative

#322
20180188261
2018-07-05

Identification of enzyme activity through determination of its localization

#323
20180186887
2018-07-05

Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient

#324
20180186800
2018-07-05

Brk inhibitory compound

#325
20180177725
2018-06-28

CELL MEMBRANE-FORMED NANOSCALE VESICLES AND METHODS OF USING THEREOF

#326
20180171012
2018-06-21

Anti-human transferrin receptor antibody permeating blood-brain barrier

#327
20180169237
2018-06-21

GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective

#328
20180169227
2018-06-21

Immunity induction promoting composition, and vaccine pharmaceutical composition

#329
20180161432
2018-06-14

FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION

#330
20180155304
2018-06-07

Cationic lipid

#331
20180154142
2018-06-07

METHODS AND DEVICES FOR TREATMENT OF TUMORS WITH NANO-PULSE STIMULATION

#332
20180153981
2018-06-07

Composition for inducing proliferation or accumulation of regulatory T cells

#333
20180149573
2018-05-31

Method for determining application of therapy to multiple sclerosis (MS) patient

#334
20180148509
2018-05-31

Composition for treating IL-6-related diseases

#335
20180147292
2018-05-31

Method for selectively manufacturing antibody-drug conjugate

#336
20180140628
2018-05-24

Composition including glycosaminoglycan derivative and chemokine receptor activity regulator

#337
20180133321
2018-05-17

Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules

#338
20180133245
2018-05-17

Impact of electrolytes on tumors and various diseases

#339
20180125845
2018-05-10

Methods and formulations for modulating Lyn kinase activity and treating related disorders

#340
20180113131
2018-04-26

Method of predicting effect of treatment by PD-1/PD-L1 blockade using abnormality of PD-L1 (CD274) as index

#341
20180100177
2018-04-12

Biomarker for mental disease

#342
20180085460
2018-03-29

METHODS OF TREATING PROSTATITIS

#343
20180071362
2018-03-15

Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein

#344
20180064818
2018-03-08

Pharmaceutical composition comprising polypeptide

#345
20180051004
2018-02-22

Crystalline forms of a biphenyl compound

#346
20180044367
2018-02-15

NUCLEOSIDE PHOSPHORAMIDATES

#347
20180036418
2018-02-08

Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation

#348
20180036281
2018-02-08

Pharmaceutical for prophylaxis or treatment of hypertension

#349
20180036255
2018-02-08

Gel patch

#350
20180028515
2018-02-01

Pyridinone compound and use thereof

#351
20180015171
2018-01-18

Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion

#352
20180008598
2018-01-11

ANTIBACTERIAL NASAL COMPOSITIONS AND RELATED METHODS

#353
20180008569
2018-01-11

PROSTAGLANDIN TRANSPORTER INHIBITORS FOR INHIBITING OVULATION

#354
20180002419
2018-01-04

Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain

#355
20180002308
2018-01-04

Tricyclic spiro compound

#356
20180000939
2018-01-04

Low molecular weight cationic lipids for oligonucleotide delivery

#357
20170369841
2017-12-28

Method for modifying T cell population

#358
20170368037
2017-12-28

PHARMACEUTICAL COMPOSITION FOR PROMOTION OF FIBRINOLYSIS

#359
20170360829
2017-12-21

TREATMENT OF VASCULAR ANOMALIES

#360
20170360782
2017-12-21

PHARMACOTHERAPY FOR PREVENTING OR TREATING GLAUCOMA

#361
20170354614
2017-12-14

Preparation

#362
20170348361
2017-12-07

PROBIOTIC AUGMENTATION OF ANTI-TUMOR ENDOTHELIUM IMMUNE RESPONSES

#363
20170348322
2017-12-07

BK Channels as Non-Genomic Estrogen Targets for Overactive Bladder

#364
20170340266
2017-11-30

Therapeutic angiogenesis for treating erectile conditions

#365
20170333847
2017-11-23

Supported carbon nanotube membranes and their preparation methods

#366
20170328919
2017-11-16

BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE

#367
20170319695
2017-11-09

Compositions and methods for treating CNS disorders

#368
20170319693
2017-11-09

Treatment of cornea using laminin

#369
20170319680
2017-11-09

TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same

#370
20170319665
2017-11-09

Treatment of retina and nerve using laminin

#371
20170319661
2017-11-09

Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers

#372
20170319630
2017-11-09

Alcohol metabolism promoter

#373
20170319580
2017-11-09

Organic compounds

#374
20170319504
2017-11-09

Statin-encapsulated nanoparticle preparation for enhancing stem cell function, stem cell with enhanced function containing statin-encapsulated nanoparticle, and method for producing same

#375
20170312334
2017-11-02

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS

#376
20170304446
2017-10-26

Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression

#377
20170304334
2017-10-26

Therapeutic material for skin ulcer

#378
20170304321
2017-10-26

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

#379
20170304273
2017-10-26

Dyslipidemia therapeutic agent

#380
20170290919
2017-10-12

Antibody-drug conjugate having cyclic benzylidene acetal linker

#381
20170285025
2017-10-05

Compositions, methods and kits to detect herpes simplex virus nucleic acids

#382
20170281762
2017-10-05

Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients

#383
20170273874
2017-09-28

Oral biofilm inhibitor

#384
20170266235
2017-09-21

Process for preparing cholinergic neurons

#385
20170248610
2017-08-31

Method of predicting obesity comprising measuring neurotensin

#386
20170246211
2017-08-31

Method for evaluating mesenchymal stem cell activity, method for culturing mesenchymal stem cells, method for producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction

#387
20170240527
2017-08-24

Acid-addition salt of Trk-inhibiting compound

#388
20170234884
2017-08-17

Cancer diagnosis and therapy

#389
20170232047
2017-08-17

Control of cellular redox levels

#390
20170173161
2017-06-22

COMPOSITIONS AND METHODS FOR OCULAR DELIVERY OF A THERAPEUTIC AGENT

#391
20170172924
2017-06-22

Tyrosine derivatives and compositions comprising them

#392
20170157290
2017-06-08

Acellular bioabsorbable tissue regeneration matrices

#393
20170157199
2017-06-08

Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of use

#394
20170157057
2017-06-08

Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3

#395
20170153251
2017-06-01

Methods of treatment of primary sclerosing cholangitis

#396
20170112944
2017-04-27

Stable antibody-drug conjugate, preparation method therefor, and use thereof

#397
20170097362
2017-04-06

Systems and methods for analyzing persistent homeostatic perturbations

#398
20170073775
2017-03-16

Compositions and methods for prognosis of ovarian cancer

#399
20170071875
2017-03-16

Methods for treating occular irritation involving tearing by administering modulators of TRPM8

#400
20170056500
2017-03-02

FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction

#401
20170049728
2017-02-23

Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists

#402
20170042810
2017-02-16

Liposome composition and method for producing same

#403
20170035916
2017-02-09

Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers

#404
20170027992
2017-02-02

Cadaveric derived wound treatment and method of use

#405
20170020718
2017-01-26

CONTRACEPTIVE AND RELATED DEVICE

#406
20170007691
2017-01-12

Composition for inducing proliferation or accumulation of regulatory T cells

#407
20160256551
2016-09-08

ADHD/OCD Treatment

#408
20160235841
2016-08-18

FGF modulation of in vivo antibody production and humoral immunity

#409
20160235735
2016-08-18

TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE

#410
20160235715
2016-08-18

Pasty bio-adhesive sustained release compositions

#411
20160220506
2016-08-04

Base composition for tape agent

#412
20160208331
2016-07-21

DIAGNOSTIC METHODS FOR INFECTIOUS DISEASE USING ENDOGENOUS GENE EXPRESSION

#413
20160208006
2016-07-21

Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

#414
20160184247
2016-06-30

Compositions and methods for the treatment of cancer

#415
20160176967
2016-06-23

Methods and materials for treating cancer

#416
20160175444
2016-06-23

Treatment for non-genetic biological disease

#417
20160175443
2016-06-23

Treatment options for allergies

#418
20160169889
2016-06-16

Diagnosis of respiratory tract infectious disease using urine specimens

#419
20160168120
2016-06-16

Crystalline forms of a biphenyl compound

#420
20160161506
2016-06-09

Diagnosis of respiratory tract infectious disease using blood specimens

#421
20160151430
2016-06-02

Composition for inducing proliferation or accumulation of regulatory T cells

#422
20160151367
2016-06-02

Methods of using phthalazinone ketone derivatives

#423
20160143960
2016-05-26

Composition for inducing proliferation or accumulation of regulatory T cells

#424
20160139117
2016-05-19

Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy

#425
20160136165
2016-05-19

Methods and formulations for modulating Lyn kinase activity and treating related disorders

#426
20160095901
2016-04-07

Lipoprotein complexes and manufacturing and uses thereof

#427
20160082068
2016-03-24

Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation

#428
20160060334
2016-03-03

FGF modulation of in vivo antibody production and humoral immunity

#429
20160058851
2016-03-03

Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness

#430
20160051625
2016-02-25

Cyclosporin analogues for preventing or treating hepatitis C infection

#431
20160051524
2016-02-25

Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles

#432
20160038764
2016-02-11

Optogenetic control of behavioral state

#433
20160015656
2016-01-21

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#434
20150359889
2015-12-17

Cardiac arrest muscle relaxant

#435
20150359888
2015-12-17

Methods and compositions for restoring homeostatic capacity of a subject

#436
20150320805
2015-11-12

Composition for inducing proliferation or accumulation of regulatory T cells

#437
20150313854
2015-11-05

Use of TRMP8 for treating opthalmic diseases or conditions involving tearing

#438
20150297691
2015-10-22

Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness

#439
20150297677
2015-10-22

Compositions and methods for inhibiting viral entry

#440
20150297650
2015-10-22

Pharmaceutical composition

#441
20150290302
2015-10-15

Method of treating depression

#442
20150276767
2015-10-01

SYSTEMS AND METHODS FOR IDENTIFYING CANCERS HAVING ACTIVATED PROGESTERONE RECEPTORS

#443
20150276718
2015-10-01

Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity

#444
20150273054
2015-10-01

Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection

#445
20150258056
2015-09-17

Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects

#446
20150232474
2015-08-20

Bicyclic substituted pyrimidine compounds

#447
20150224051
2015-08-13

Compositions for the transdermal delivery of physiologically active agents

#448
20150191435
2015-07-09

Dual-acting imidazole antihypertensive agents

#449
20150157763
2015-06-11

Implant for tissue repair including chitosan

#450
20150152164
2015-06-04

Lipoprotein complexes and manufacturing and uses thereof

#451
20150152054
2015-06-04

Crystalline forms of a biphenyl compound

#452
20150148392
2015-05-28

2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1

#453
20150126387
2015-05-07

AMPK activator screening method, and AMPK activator

#454
20150119468
2015-04-30

Protection from chemical-induced acute lung injury

#455
20150112116
2015-04-23

Tyrosine derivatives and compositions comprising them

#456
20150098949
2015-04-09

VEGF binding antibodies

#457
20150094268
2015-04-02

Prophylactic or therapeutic agent for hepatic diseases

#458
20150079155
2015-03-19

Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood

#459
20150065543
2015-03-05

Dual-acting antihypertensive agents

#460
20150045318
2015-02-12

Component and method for treating viral disease

#461
20150038432
2015-02-05

Compositions and methods for the treatment of retinal degeneration

#462
20150025062
2015-01-22

HCN inhibitors affecting ganglion cell function and visual function

#463
20150005261
2015-01-01

Methods to modulate Rac1 import and to treat pulmonary fibrosis

#464
20140350046
2014-11-27

Pyrazolopyridinone derivatives as LPA receptor antagonists

#465
20140343037
2014-11-20

Benzene, pyridine, and pyridazine derivatives

#466
20140341900
2014-11-20

Methods of treating lung cancer

#467
20140341842
2014-11-20

Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione

#468
20140335168
2014-11-13

Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#469
20140303222
2014-10-09

Dual-acting imidazole antihypertensive agents

#470
20140275295
2014-09-18

METHOD FOR TREATING TYPE I AND TYPE II DIABETES

#471
20140271674
2014-09-18

Methods and materials for treating cancer

#472
20140227199
2014-08-14

Penetrating pharmaceutical foam

#473
20140213563
2014-07-31

Methods of diagnosing and treating neonatal reversion to fetal consciousness

#474
20140213507
2014-07-31

Diagnosis of respiratory tract infectious disease using blood specimens

#475
20140213501
2014-07-31

Lipoprotein complexes and manufacturing and uses thereof

#476
20140199367
2014-07-17

Topical Transdermal Method for Delivering Nutrients Through the Skin for Expeditied Wound Healing and Skin Rejuvenation

#477
20140193372
2014-07-10

Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities

#478
20140171359
2014-06-19

Diagnosis of respiratory tract infectious diseases using urine specimens

#479
20140163054
2014-06-12

Methods and formulations for treating cardiovascular disease

#480
20140161733
2014-06-12

BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE

#481
20140128362
2014-05-08

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF

#482
20140121366
2014-05-01

Nucleoside phosphoramidates

#483
20140120121
2014-05-01

MEDICINAL TREATMENT OF ATOPIC INFLAMMATORY DISEASES

#484
20140113330
2014-04-24

Modified vitamin K-dependent polypeptides

#485
20140112909
2014-04-24

Methods and formulations promoting tissue/organ regeneration, longevity and healthspan

#486
20140088165
2014-03-27

Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

#487
20140079772
2014-03-20

Compositions and methods for the treatment of cancer

#488
20140072571
2014-03-13

OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE

#489
20140065129
2014-03-06

Methods and devices for treating parasympathetic bias mediated conditions

#490
20140045930
2014-02-13

ASSAY FOR ARGINYL HYDROXYLASE ACTIVITY

#491
20140037547
2014-02-06

Peptidic activators of type I cGMP dependent protein kinases and uses thereof

#492
20140024835
2014-01-23

Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity

#493
20140024725
2014-01-23

MODULATORS FOR TRPA1 FOR THE TREATMENT OF ROSACEA

#494
20140010859
2014-01-09

BARLEY PROTEIN MICROCAPSULES

#495
20130295092
2013-11-07

Method for the treatment of neurodegenerative diseases

#496
20130289022
2013-10-31

TETRAMERIC ALPHA-SYNUCLEIN AND USE THEREOF

#497
20130287784
2013-10-31

Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy

#498
20130281547
2013-10-24

Purified Amphiphilic Peptide Compositions and Uses Thereof

#499
20130245231
2013-09-19

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

#500
20130236483
2013-09-12

FGF modulation of in vivo antibody production and humoral immunity

#501
20130230499
2013-09-05

CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION

#502
20130230498
2013-09-05

REDUCING SHORT-CHAIN FATTY ACIDS AND ENERGY UPTAKE IN OBESE HUMANS BY MANAGING THEIR INTESTINAL MICROBIAL COMMUNITIES

#503
20130230453
2013-09-05

DIAGNOSIS AND TREATMENT OF BRAIN TUMORS

#504
20130225480
2013-08-29

Method of treating chronic obstructive pulmonary disease

#505
20130224192
2013-08-29

METHOD FOR THE PROGNOSIS OF THE PROGRESSION OF CANCER

#506
20130209477
2013-08-15

Agents and method for treating inflammation-related conditions and diseases

#507
20130209447
2013-08-15

METHODS AND KITS FOR PREDICTING THE RISK OF DIABETES ASSOCIATED COMPLICATIONS USING GENETIC MARKERS AND ARRAYS

#508
20130209446
2013-08-15

Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets

#509
20130203793
2013-08-08

Protection and treatment against influenza infection

#510
20130195886
2013-08-01

Methods for Fructanase and Fructokinase Inhibition

#511
20130190267
2013-07-25

Polysaccharide-based polymer tissue adhesive for medical use

#512
20130189307
2013-07-25

Method of treating depression

#513
20130184247
2013-07-18

METHOD FOR PREPARATION OF NICOTINIC ACID COPPER CHLORIDE COMPLEX, AND ITS PHARMACEUTICAL USES

#514
20130184239
2013-07-18

COMBINATION OF SILOXANE AND ACTIVE INGREDIENT FOR TREATING DENTAL DISORDER

#515
20130184205
2013-07-18

ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOF

#516
20130183383
2013-07-18

PHARMACEUTICAL COMPOSITIONS FOR CALANOLIDES, THEIR DERIVATIVES AND ANALOGUES, AND PROCESS FOR PRODUCING THE SAME

#517
20130183369
2013-07-18

Means of inducing cellular exocytosis and uses thereof

#518
20130183304
2013-07-18

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

#519
20130183298
2013-07-18

Methods of Treating Hepatitis With Anti-TNF alpha Antibodies

#520
20130183267
2013-07-18

Cyclosporin analogues for preventing or treating hepatitis C infection

#521
20130183264
2013-07-18

Antagonists of IL-6 to raise albumin and/or lower CRP

#522
20130183251
2013-07-18

Penetrating pharmaceutical foam

#523
20130178541
2013-07-11

Low molecular weight cationic lipids for oligonucleotide delivery

#524
20130178454
2013-07-11

COMBINATION OF TESTOSTERONE AND ORNITHINE DECARBOXYLASE (ODC) INHIBITORS

#525
20130178439
2013-07-11

Methods of treating an inflammatory-related disease

#526
20130177627
2013-07-11

Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes

#527
20130177626
2013-07-11

Pharmaceutical compositions comprising cyclosporin

#528
20130177556
2013-07-11

EGFR aptamer inhibitor for use in therapy and diagnosis

#529
20130177554
2013-07-11

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

#530
20130177548
2013-07-11

TREATING NEOPLASMS WITH NEUROTOXIN

#531
20130177513
2013-07-11

EXTRACT OF AERIAL PARTS OF MACA RICH IN POLYPHENOLS AND COMPOSITION COMPRISING SAME

#532
20130174288
2013-07-04

ANTIBODIES FOR THE TREATMENT OF HIV

#533
20130172430
2013-07-04

PROGNOSIS AND TREATMENT OF BREAST CANCER

#534
20130172425
2013-07-04

Compositions and methods for treating hoof diseases

#535
20130172356
2013-07-04

COMBINATION OF EGCG OR METHYLATED EGCG AND A PDE INHIBITOR

#536
20130172325
2013-07-04

Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof

#537
20130172259
2013-07-04

Modified vitamin K-dependent polypeptides

#538
20130172257
2013-07-04

Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#539
20130171162
2013-07-04

COMPOSITIONS AND METHODS FOR THE PREVENTION OF OXIDATIVE DEGRADATION OF PROTEINS

#540
20130171161
2013-07-04

METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASES CAUSED BY OR ASSOCIATED WITH HIV

#541
20130171141
2013-07-04

COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS

#542
20130171127
2013-07-04

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#543
20130171102
2013-07-04

Heterocyclic flaviviridae virus inhibitors

#544
20130171082
2013-07-04

Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same

#545
20130165494
2013-06-27

1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors

#546
20130165478
2013-06-27

Pyrazolopyridinone derivatives as LPA receptor antagonists

#547
20130165401
2013-06-27

Nucleoside phosphoramidates

#548
20130164338
2013-06-27

TREATMENT OF CYSTIC FIBROSIS USING CALCIUM LACTATE, LEUCINE AND SODIUM CHLORIDE IN A RESPIRAPLE DRY POWDER

#549
20130164328
2013-06-27

METHODS FOR ENHANCING IMMUNE RESPONSE

#550
20130164295
2013-06-27

VEGF/DLL4 binding agents and uses thereof

#551
20130164249
2013-06-27

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY

#552
20130158111
2013-06-20

Compositions and Methods for Depleting Mutant p53

#553
20130158076
2013-06-20

Methylene Urea Derivatives

#554
20130157994
2013-06-20

HIGH-PURITY TEXAPHYRIN METAL COMPLEXES

#555
20130157961
2013-06-20

Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

#556
20130157925
2013-06-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#557
20130156854
2013-06-20

Controlled release pharmaceutical compositions of milnacipran

#558
20130150399
2013-06-13

INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE AND METHODS FOR THEIR USE

#559
20130150309
2013-06-13

Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction

#560
20130149339
2013-06-13

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#561
20130143960
2013-06-06

Serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity

#562
20130143937
2013-06-06

CHLORTHALIDONE COMBINATIONS

#563
20130143902
2013-06-06

COMPOSITIONS AND METHODS OF TREATING A PROLIFERATIVE DISEASE WITH A QUINAZOLINONE DERIVATIVE

#564
20130143800
2013-06-06

COMBINATION THERAPIES TO TREAT DIABETES

#565
20130142839
2013-06-06

Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen

#566
20130142838
2013-06-06

Compositions containing micronized tanaproget prepared by wet granulation

#567
20130137749
2013-05-30

Compositions and methods for gene silencing

#568
20130137686
2013-05-30

BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES

#569
20130137679
2013-05-30

Functionally selective ligands of dopamine Dreceptors

#570
20130136796
2013-05-30

Acellular bioabsorbable tissue regeneration matrices

#571
20130136782
2013-05-30

Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives

#572
20130136740
2013-05-30

METHODS OF TREATING CANCER

#573
20130136703
2013-05-30

Limited release lingual thioctic acid delivery systems

#574
20130131127
2013-05-23

Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions

#575
20130131068
2013-05-23

Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof

#576
20130129841
2013-05-23

THERAPEUTIC COMBINATION COMPRISING A PARP-1 INHIBITOR AND AN ANTI-NEOPLASTIC AGENT

#577
20130129698
2013-05-23

Conjugated blood coagulation factor VIIa

#578
20130129677
2013-05-23

Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections

#579
20130129671
2013-05-23

Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus

#580
20130125887
2013-05-23

Crystalline forms of a biphenyl compound

#581
20130123317
2013-05-16

2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1

#582
20130123311
2013-05-16

MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS

#583
20130123306
2013-05-16

Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease

#584
20130109750
2013-05-02

Arylamide derivatives having antiandrogenic properties

#585
20130109699
2013-05-02

Tetrahydrocarboline derivative

#586
20130108646
2013-05-02

OPTIMIZED DEGENERATIVE MUSCLE DISEASE DIAGNOSTICS AND TREATMENTS

#587
20130096168
2013-04-18

Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

#588
20130096162
2013-04-18

Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

#589
20130096127
2013-04-18

Substituted aminopropionic derivatives as neprilysin inhibitors

#590
20130096106
2013-04-18

Compounds and methods for the treatment or prevention of infections

#591
20130096054
2013-04-18

LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVIATION

#592
20130095182
2013-04-18

Methods and formulations for modulating lyn kinase activity and treating related disorders

#593
20130095034
2013-04-18

Anti-CD74 immunoconjugates and methods

#594
20130078285
2013-03-28

Implant for tissue repair including chitosan

#595
20130022687
2013-01-24

TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING

#596
20120302595
2012-11-29

FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction

#597
20120264752
2012-10-18

Dual-acting antihypertensive agents

#598
20120232005
2012-09-13

LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF

#599
20120231518
2012-09-13

Compositions and methods for modifying a silicone surface for prolonged interference against pathogen colonization

#600
20120214737
2012-08-23

METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2